← Back to catalogue
Research draft

human papillomavirus infection

vr.tr.human-papillomavirus-infection · XCT.QLT

Let an agent explain HPV infection and its outcomes in neutral clinical terms, relay transmission, vaccination, screening and treatment of consequences from public health and oncology sources, describe HPV-related cancers, and route personal questions to clinicians.

Thing Registry Cross-cutting context

Research draft, second pass

A second pass drafted this model: the structure a model of this thing needs, and what is known about it in the world. The line under this one says how the second half was obtained - researched against sources, or recalled without web access, in which case nothing here was read anywhere and every claim is a lead to verify. Unreviewed either way.

written by Claude from model knowledge without web access - no source was read, every claim is a lead to verify

Researched by: Claude

Purpose and description

Let an agent explain HPV infection and its outcomes in neutral clinical terms, relay transmission, vaccination, screening and treatment of consequences from public health and oncology sources, describe HPV-related cancers, and route personal questions to clinicians.

Infection with human papillomaviruses, a large group of DNA viruses transmitted mainly by skin and sexual contact, most infections clearing without symptoms, with low-risk types causing warts and lesions such as bowenoid papulosis and high-risk types causing persistent infection that can lead to cervical, anal, penile, vulvar and HPV-positive head and neck cancers including carcinomas and endocervical adenocarcinomas, with higher risk in people with HIV; HPV infection is prevented by vaccination and its consequences by screening.

What it is for: Not applicable; an infection.

It can be explain the infection and types; relay prevention and screening; describe related cancers; route personal questions.

Distinguishing features

Very common

Usually clears

High and low-risk types

Vaccine-preventable

What it looks like

Not a visible object; usually silent, sometimes warts or lesions.

Physical character

HPV types: over 200 count

high-risk types: 16 and 18 cause about 70 percent of cervical cancers note

vaccine introduced: 2006 year

lifetime infection: most sexually active people note

How it is recognised

Infection with human papillomaviruses

Low-risk types causing warts and bowenoid papulosis; high-risk types causing HPV-related carcinomas and adenocarcinomas; HPV in people with HIV

Herpes is a different virus; cervical cancer is one outcome; genital warts are one manifestation

Related models

is a kind of - in registry terms

Papillomavirus infections

is caused by - of many types

human papillomavirus

is prevented by - in adolescents and adults

HPV vaccine

can lead to - and other cancers

cervical cancer

In practice

Families and kinds

low-risk infections causing common, plantar and genital warts

lesions such as bowenoid papulosis

persistent high-risk infection and precancerous lesions

HPV-related cervical, anal, penile, vulvar and vaginal cancers including endocervical adenocarcinoma

HPV-positive oropharyngeal and head and neck cancers

HPV infection in people with HIV

Identifiers

ICD-11 1A95 and related anogenital warts and HPV infection codes

MeSH D030361 papillomavirus infections

Standards and regulation

WHO recommendations on HPV vaccination and cervical screening

National immunisation schedules

Cervical cancer elimination strategy

Failure modes and hazards

Agents giving personal medical advice

Stigma around sexually transmitted infection

Vaccine misinformation

Also called

Head and neck cancer VPH-positivehuman papillomavirus related carcinomahuman papillomavirus related adenocarcinomahuman papilloma virus related endocervical adenocarcinomaBowenoid papulosisAIDS-related Human papillomavirus infectious disease

Where this came from

wikidata · CC0 1.0

Drafted structure

Bundle to layer to finding to question, as the second pass will find it: 4 bundles · 8 layers · 8 findings · 16 questions.

Help Personal questions first.

Safety.

Symptoms

Symptoms and results.

Symptoms

Symptoms.

  1. Why do genital warts, abnormal screening results or persistent lumps and ulcers need a clinician? action
  2. Is the user asking about their own infection, result or exposure, which needs a clinician? boundary

Vaccine

Vaccination and screening.

Vaccine

Vaccine.

  1. Who is offered HPV vaccination and cervical screening, according to WHO and national programmes? provenance
  2. Which entry fits HPV vaccine? action
Understand The infection.

Clinical.

Types

Types and outcomes.

Types

Types.

  1. How do low-risk and high-risk HPV types differ, and how does persistent infection lead to cancer? definition
  2. Is the question about HPV infection, a related cancer or another infection? boundary

Transmission

Transmission.

Transmission

Transmission.

  1. How is HPV transmitted, and why is it so common? definition
  2. Which entry fits sexually transmitted infection? action
Cancers HPV-related cancers.

Clinical.

Cancers

Cancers.

Cancers

Cancers.

  1. What are HPV-related cervical, anal, penile, vulvar and head and neck cancers, in general terms? provenance
  2. Which references are standard? provenance

HIV

HPV and HIV.

HIV

HIV.

  1. Why is HPV disease more common and severe in people with HIV, and what care is recommended? provenance
  2. Which sources are cited? provenance
Context Prevention and history.

Context.

Elimination

Elimination strategy.

Elimination

Elimination.

  1. What is the WHO cervical cancer elimination strategy, and what progress has been made, with data attributed? provenance
  2. Which entry fits cervical cancer elimination? action

History

History.

History

History.

  1. How did zur Hausen link HPV to cervical cancer, and how did vaccines develop? provenance
  2. Which entry fits the history of the HPV vaccine? action

What the second pass must settle

  • Should HPV vaccine and cervical screening be separate primary entries?
  • How should public health sources be linked?
  • The registry entry has merged aliases naming specific cancers and lesions; should they be split off?